| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/05/2014 | CN102727846B Traditional Chinese medicine decoction used for treating common cold, and preparation method thereof |
| 02/05/2014 | CN102702212B N-(2-subtituted acyl) pyrazol derritol and application thereof as medicament |
| 02/05/2014 | CN102641349B Traditional Chinese medicine composite for resisting ephedrine damage and production technology thereof |
| 02/05/2014 | CN102552706B Medicine for treating vascular dementia and preparation method thereof |
| 02/05/2014 | CN102512619B Traditional Chinese medicine composition used for treating headache |
| 02/05/2014 | CN102512435B Application of scutellarin methyl ester and medicinal composition as well as preparation thereof |
| 02/05/2014 | CN102216272B 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds |
| 02/04/2014 | US8642760 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 02/04/2014 | US8642662 Methods of using derivatives of (−)-venlafaxine |
| 02/04/2014 | US8642615 Methods of using 8-carboxamido-2,6-methano-3-benzazocines |
| 02/04/2014 | US8642605 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines |
| 02/04/2014 | US8642603 Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof |
| 02/04/2014 | US8642594 Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors |
| 02/04/2014 | US8642588 Short-acting benzodiazepine salts and their polymorphic forms |
| 02/04/2014 | US8642552 Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy |
| 02/04/2014 | US8642331 Bone marrow-derived mesenchymal stem cells as a source of neural progenitors |
| 02/04/2014 | US8642044 Prevention and treatment of amyloidogenic disease |
| 02/04/2014 | CA2727642C Synthesis of cyclosporin analogs |
| 02/04/2014 | CA2697520C Use of lyophilised reduced diaminophenothiazines in the treatment of tau mediated neurological disorders |
| 02/04/2014 | CA2666750C Phenylpropionamide compounds and the use thereof |
| 02/04/2014 | CA2620032C Polymer conjugates of k-252a and derivatives thereof |
| 02/04/2014 | CA2507055C Treatment of prion-induced diseases by administration of anti-prion antibodies |
| 02/04/2014 | CA2498260C Pharmaceutical formulations of modafinil |
| 01/30/2014 | WO2014018741A1 Heterocyclic flavone derivatives, compositions, and methods related thereto |
| 01/30/2014 | WO2014018571A2 Use of cse inhibitors for the treatment of cutaneous injuries or conditions and sleep-related breathing disorders |
| 01/30/2014 | WO2014018570A1 Cystathionine-υ-lyase (cse) inhibitors |
| 01/30/2014 | WO2014018569A1 Cystathionine-y-gamma-lyase (cse) inhibitors |
| 01/30/2014 | WO2014017595A1 Patch |
| 01/30/2014 | WO2014017594A1 Adhesive patch |
| 01/30/2014 | WO2014017593A1 Adhesive patch and production method therefor |
| 01/30/2014 | WO2014017569A1 Pharmaceutical product for lowering blood ldl |
| 01/30/2014 | WO2014017462A1 Pharmaceutical composition for inhibiting abnormal spine formation |
| 01/30/2014 | WO2014017243A1 Sleep quality improving agent |
| 01/30/2014 | WO2014016789A1 Pyrazolo[3,4-d]pyrimidin-4(5h)-one derivatives as pde9 inhibitors |
| 01/30/2014 | WO2014016653A1 Pharmaceutical composition comprising diamorphine for intranasal administration |
| 01/30/2014 | WO2014016267A1 Benzisoxazole modulators of neurogenesis |
| 01/30/2014 | WO2014016003A1 Use of biotin for the treatment of multiple sclerosis |
| 01/30/2014 | WO2014015993A1 Bicyclic aza-amides for treatment of psychiatric disorders |
| 01/30/2014 | WO2014015523A1 Novel heteroaryl and heterocycle compounds, compositions and methods |
| 01/30/2014 | WO2014015436A1 Apparatus and method of controlling the rate of nicotine delivery |
| 01/30/2014 | WO2013184794A3 Peripheral kappa receptor agonists for reducing pain and inflammation |
| 01/30/2014 | WO2013181296A3 Compositions and methods for managing weight |
| 01/30/2014 | US20140033335 Immunoglobulin 2 |
| 01/30/2014 | US20140031589 Process for the preparation of and crystalline forms of optical enantiomers of modafinil |
| 01/30/2014 | US20140030523 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 01/30/2014 | US20140030331 Method of treating multiple sclerosis |
| 01/30/2014 | US20140030316 Transdermal administration of fentanyl and analogs thereof |
| 01/30/2014 | US20140030251 Composition and method for reducing tissue damage from inflammatory disorder or pathogenic infection |
| 01/29/2014 | EP2690102A1 Bicyclic aza-amides for treatment of psychiatric disorders |
| 01/29/2014 | EP2690088A1 Mixed crystal agomelatine (form-viii), preparation method and use thereof and pharmaceutical composition containing same |
| 01/29/2014 | EP2690087A1 New crystal form vii of agomelatine, preparation method and use thereof and pharmaceutical composition containing same |
| 01/29/2014 | EP2689782A1 Improving memory in subjects with mini-mental state examination of 24-26 |
| 01/29/2014 | EP2688902A1 Derivatives of allopregnanolone and of epiallopregnanolone and uses thereof for treating a neuropathological condition |
| 01/29/2014 | EP2688891A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use |
| 01/29/2014 | EP2688890A1 Substituted fused tricyclic compounds, compositions and medicinal applications thereof |
| 01/29/2014 | EP2688884A1 Amorphous form of vilazodone hydrochloride and process for its preparation |
| 01/29/2014 | EP2688866A1 Trpv1 antagonists |
| 01/29/2014 | EP2688582A1 Neuroprotective peptides |
| 01/29/2014 | EP2688571A1 Myelin regeneration with androgens |
| 01/29/2014 | EP2688570A2 6-substituted estradiol derivatives for use in remyelination of nerve axons |
| 01/29/2014 | EP2516437B1 Disubstituted heteroaryl-fused pyridines |
| 01/29/2014 | EP2515647B1 Pheromone compositions and methods of use |
| 01/29/2014 | EP2493894B1 Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands |
| 01/29/2014 | EP2411030B1 Herbal extract of Casia tora leaves for use in the treatment of anxiety disorders |
| 01/29/2014 | EP2181709B1 Synergic combination of analgesic compounds |
| 01/29/2014 | EP2146961B1 N-oxide and/or di-n-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles |
| 01/29/2014 | CN103547580A Substituted fused tricyclic compounds, compositions and medicinal applications thereof |
| 01/29/2014 | CN103547289A Methods and compositions for treating alzheimer's disease |
| 01/29/2014 | CN103547264A Use of sigma ligands in diabetes type-2 associated pain |
| 01/29/2014 | CN103547262A Novel uses of licochalcone A |
| 01/29/2014 | CN103547260A Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a CNS disorder |
| 01/29/2014 | CN103547174A Food, particularly a beverage for human consumption |
| 01/29/2014 | CN103540513A Beautifying lucid ganoderma composition, medicated liquor and manufacturing method and application of medicated liquor |
| 01/29/2014 | CN103540478A Formula of lucid ganoderma health-care wine |
| 01/29/2014 | CN103540404A Compound Chinese mugwort essential oil |
| 01/29/2014 | CN103539863A Application of low-sulfated heteroglycan prepared from brown alga and rich in glucuronic acid in preparation of medicament and health-care products for treating Parkinson's disease |
| 01/29/2014 | CN103539857A Antibodies against amyloid-beta peptide |
| 01/29/2014 | CN103539834A Chemerin derived peptide and expressed gene and application thereof |
| 01/29/2014 | CN103539791A Modulators of the GPR119 receptor and the treatment of disorders related thereto |
| 01/29/2014 | CN103539785A 大麻素受体调节剂 Cannabinoid receptor modulators |
| 01/29/2014 | CN103539769A Macrocyclic compounds useful as inhibitors of kinases and HSP90 |
| 01/29/2014 | CN103539735A Crystalline forms of a prolyl hydroxylase inhibitor |
| 01/29/2014 | CN103536916A Methods for treating tweak-related conditions |
| 01/29/2014 | CN103536901A Application of recombined ganoderma lucidum immunomodulatory protein in preparing drug for treating parkinsonism |
| 01/29/2014 | CN103536897A Compound for inhibiting aggregation of amyloid polypeptide as well as preparation method and application thereof |
| 01/29/2014 | CN103536880A Chinese medicine for treating type II diabetic peripheral neuropathy |
| 01/29/2014 | CN103536873A Traditional Chinese medicine for treating vertigo caused by deficiency of both liver and kidney |
| 01/29/2014 | CN103536867A Prescription for reinforcing body immunity |
| 01/29/2014 | CN103536865A Traditional Chinese medicine composition for treating agrypnia |
| 01/29/2014 | CN103536864A Chinese herbal medicine drug treatment composition |
| 01/29/2014 | CN103536860A Health care product capable of improving sleep |
| 01/29/2014 | CN103536854A Traditional Chinese medicine composition capable of effectively treating neurasthenia, and preparation method thereof |
| 01/29/2014 | CN103536852A Pharmaceutical composition for treating mental disease and use thereof |
| 01/29/2014 | CN103536832A Traditional Chinese medicinal composition for treating masturbation or excessive indulgence sequela |
| 01/29/2014 | CN103536829A Traditional Chinese medicinal prescription for invigorating intelligence and tonifying brain |
| 01/29/2014 | CN103536822A Medicine for treating osteoproliferation and lumbar disc herniation |
| 01/29/2014 | CN103536820A Refreshing lucid ganoderma composition, medicinal tea and manufacturing method and application of medicinal tea |
| 01/29/2014 | CN103536793A Composition with functions of clearing away heat and toxic materials and removing fire as well as preparation method thereof |
| 01/29/2014 | CN103536778A Traditional Chinese medicine preparation for treating cephalagra |
| 01/29/2014 | CN103536757A Traditional Chinese medicine composition having effects of tonifying kidney, replenishing essence, tonifying qi, nourishing blood and consolidating basis, and preparation method and application thereof |